Exponent (NASDAQ:EXPO) Announces Earnings Results

Exponent (NASDAQ:EXPO) released its earnings results on Thursday. The business services provider reported $0.60 earnings per share for the quarter, topping analysts’ consensus estimates of $0.55 by $0.05, FiscalAI reports. Exponent had a return on equity of 29.63% and a net margin of 17.67%.The business had revenue of $171.61 million for the quarter, compared to analyst estimates of $144.99 million. During the same quarter last year, the firm posted $0.52 earnings per share. The business’s revenue was up 12.0% compared to the same quarter last year.

Here are the key takeaways from Exponent’s conference call:

• Strong second-quarter execution: Net revenue increased 12% to $148.9 million, EBITDA rose 16% with margin expanding to 28.7%, and diluted EPS grew 15% to $0.60. Results benefited from higher utilization and a large user research engagement.
• Exponent raised its 2026 outlook, now expecting 9%–10% net revenue growth and EBITDA margins of 27.8%–28.1%; third-quarter net revenue is projected to grow 8%–10%.
• Demand for AI-enabled products is expanding Exponent’s proactive user research work across consumer electronics, wearables, medical devices, and other technologies, while reactive opportunities are growing in advanced driver-assistance systems and data-center infrastructure.
• The board authorized an additional $50 million share-repurchase capacity after $211 million of buybacks over the past 12 months, alongside $61 million in dividends; management expects more than $100 million of free cash flow in the second half of 2026.
• Management indicated that the large user research study that represented approximately 4% of second-quarter net revenue moderated late in the quarter and is expected to contribute about 2% of net revenue for the remainder of the year, while fourth-quarter utilization will face normal seasonal pressure.

Exponent Stock Up 3.5%

NASDAQ:EXPO traded up $2.28 during mid-day trading on Friday, reaching $66.85. The company’s stock had a trading volume of 1,269,859 shares, compared to its average volume of 517,001. Exponent has a 1 year low of $51.91 and a 1 year high of $81.95. The stock has a fifty day moving average of $60.00 and a 200-day moving average of $65.23. The firm has a market capitalization of $3.24 billion, a PE ratio of 29.98 and a beta of 0.72.

Exponent Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 18th. Investors of record on Friday, September 4th will be paid a $0.31 dividend. The ex-dividend date of this dividend is Friday, September 4th. This represents a $1.24 dividend on an annualized basis and a yield of 1.9%. Exponent’s dividend payout ratio is 55.61%.

Insider Buying and Selling at Exponent

In other news, VP Joseph Rakow sold 2,945 shares of the business’s stock in a transaction dated Wednesday, May 13th. The shares were sold at an average price of $54.66, for a total value of $160,973.70. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, VP Bradley A. James sold 2,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 26th. The stock was sold at an average price of $57.47, for a total transaction of $114,940.00. Following the completion of the sale, the vice president directly owned 1,105 shares of the company’s stock, valued at $63,504.35. The trade was a 64.41% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 15,324 shares of company stock worth $855,019. Company insiders own 1.60% of the company’s stock.

Institutional Trading of Exponent

Hedge funds have recently bought and sold shares of the stock. UMB Bank n.a. increased its holdings in shares of Exponent by 54.8% in the 4th quarter. UMB Bank n.a. now owns 904 shares of the business services provider’s stock valued at $63,000 after acquiring an additional 320 shares during the period. Kestra Advisory Services LLC purchased a new stake in shares of Exponent during the 4th quarter worth $78,000. FORA Capital LLC purchased a new stake in shares of Exponent during the 2nd quarter worth $228,000. nVerses Capital LLC bought a new stake in Exponent during the fourth quarter valued at about $218,000. Finally, United Services Automobile Association bought a new stake in Exponent during the first quarter valued at about $270,000. Hedge funds and other institutional investors own 92.37% of the company’s stock.

Trending Headlines about Exponent

Here are the key news stories impacting Exponent this week:

• Positive Sentiment: Q2 earnings and revenue exceeded expectations: Exponent reported adjusted earnings of $0.60 per share versus the $0.55 consensus estimate. Revenue reached approximately $171.6 million, while operating profit rose 63.1% year over year to $28.0 million. Exponent Q2 earnings report
• Positive Sentiment: Growth outlook raised: Management increased its 2026 net revenue growth forecast to 9%–10%, citing expanding demand for services related to artificial intelligence. The improved guidance reinforces expectations for continued business momentum. Exponent raises 2026 growth outlook
• Positive Sentiment: JPMorgan raised its price target: JPMorgan Chase increased its target from $80 to $90 and assigned an “overweight” rating, implying substantial potential appreciation from the referenced $66.94 price. JPMorgan raises Exponent price target
• Positive Sentiment: Capital returns increased: The board declared a quarterly dividend of $0.31 per share and expanded the company’s stock-repurchase authorization by $50 million. Exponent dividend and repurchase announcement
• Neutral Sentiment: The dividend offers an annualized yield of roughly 1.9%, with payment scheduled for September 18 to shareholders of record on September 4.
• Negative Sentiment: Insider-trading data showed 17 reported insider sales and no purchases over the past six months, which may raise a modest sentiment concern. Quarterly operating cash flow was also negative at $1.0 million, although capital spending remained limited at $2.5 million.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the stock. UBS Group set a $72.00 price target on shares of Exponent and gave the stock a “neutral” rating in a report on Friday. Weiss Ratings reiterated a “hold (c-)” rating on shares of Exponent in a report on Friday, July 17th. Finally, JPMorgan Chase & Co. upped their target price on shares of Exponent from $80.00 to $90.00 and gave the stock an “overweight” rating in a research note on Friday. Two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $81.00.

Exponent Company Profile

Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.